调强放疗时代游离组织瓣重建切除后口腔癌的放射性骨坏死发生率
这项回顾性研究纳入2000至2019年间接受游离组织瓣重建及术后调强放疗的口腔癌患者155例,评估≥2级放射性骨坏死(ORN)的危险因素。随访中位32.6个月,14例(9.0%)发生≥2级ORN,放疗后拔牙与ORN显著相关;骨皮瓣与软组织重建的ORN风险相当。
要点
- 155例口腔癌患者中,14例(9.0%)发生≥2级ORN,中位发生时间9.8个月。
- 放疗后拔牙与ORN发生显著相关。
- 骨皮瓣与软组织重建的ORN风险相当,骨皮瓣可安全实施。
核心结论
- 切除后口腔癌采用骨皮瓣或软组织重建,ORN风险相当。
- 骨皮瓣可安全实施,无需额外担心下颌骨ORN。
研究设计与样本
- 回顾性研究,纳入2000至2019年间接受游离组织瓣重建及术后调强放疗的口腔癌患者155例。
主要发现
- 患者51%为男性,28%为当前吸烟者,平均年龄62±11岁;中位随访32.6个月(范围1.0-190.6)。
- 38例(25%)采用腓骨游离瓣行下颌骨重建,117例(76%)采用软组织重建。
- 14例(9.0%)发生≥2级ORN,发生于调强放疗后中位9.8个月(范围2.4-61.5)。
- 放疗后拔牙与ORN显著相关。
- 1年和10年ORN发生率分别为5.2%和10%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Resected oral cavity carcinoma defects are often reconstructed with osteocutaneous or soft-tissue free flaps, but risk of osteoradionecrosis (ORN) is unknown. METHODS: This retrospective study included oral cavity carcinoma treated with free-tissue reconstruction and postoperative IMRT between 2000 and 2019. Risk-regression assessed risk factors for grade ≥2 ORN. RESULTS: One hundred fifty-five patients (51% male, 28% current smokers, mean age 62 ± 11 years) were included. Median follow-up was 32.6 months (range, 1.0-190.6). Thirty-eight (25%) patients had fibular free flap for mandibular reconstruction, whereas 117 (76%) had soft-tissue reconstruction. Grade ≥2 ORN occurred in 14 (9.0%) patients, at a median 9.8 months (range, 2.4-61.5) after IMRT. Post-radiation teeth extraction was significantly associated with ORN. One-year and 10-year ORN rates were 5.2% and 10%, respectively. CONCLUSIONS: ORN risk was comparable between osteocutaneous and soft-tissue reconstruction for resected oral cavity carcinoma. Osteocutaneous flaps can be safely performed with no excess concern for mandibular ORN.
引用
- Wu SS, Hong H, Fritz M, et al. Rates of osteoradionecrosis in resected oral cavity cancer reconstructed with free tissue transfer in the intensity-modulated radiotherapy era. Head Neck. 2023. PMID: 36808674. doi:10.1002/hed.27310
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。